1. Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence–Based Data Analyses of a National Multicenter Prospective Registry. Issue 1 (9th December 2022) Authors: Fernández‐Carballido, Cristina; Sanchez‐Piedra, Carlos; Valls, Raquel; Garg, Kristin; Sánchez‐Alonso, Fernando; Artigas, Laura; Mas, José Manuel; Jovaní, Vega; Manrique, Sara; Campos, Cristina; Freire, Mercedes; Martínez‐González, Olga; Castrejón, Isabel; Perella, Chiara; Coma, Mireia; van der Ho... Journal: Arthritis care & research Issue: Volume 75:Issue 1(2023) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0235 SECUKINUMAB IMPROVES AXIAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NSAIDS: PRIMARY ANALYSIS OF THE MAXIMISE TRIAL. (June 2019) Authors: Baraliakos, Xenofon; Coates, Laura C; Gossec, Laure; Jeka, Sławomir; Varela, Antonio Mera; Schulz, Barbara; Rissler, Michael; Gupta, Ayan Das; Perella, Chiara; Pournara, Effie Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P184 Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial. (26th April 2021) Authors: Baraliakos, Xenofon; Gossec, Laure; Pournara, Effie; Jeka, Slawomir; Blanco, Ricardo; D'Angelo, Salvatore; Schett, Georg; Schulz, Barbara; Rissler, Michael; Whyms, Dermot; Perella, Chiara; Coates, Laura C Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P186 Secukinumab effectiveness and safety in patients with active psoriatic arthritis or ankylosing spondylitis: interim analysis of an observational study in the real-world setting. (26th April 2021) Authors: Gaffney, Karl; Gullick, Nicola; Kiltz, Uta; Sfikakis, Petros; Theodoridou, Athina; Brandt-Jürgens, Jan; Lespessailles, Eric; Perella, Chiara; Pournara, Effie; Schulz, Barbara; Veit, Justyna Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P188 Secukinumab provides significant improvement of spinal pain and lowers disease activity in patients with axial spondyloarthritis: 24-week results from a randomised controlled Phase 3b trial. (26th April 2021) Authors: Marzo-Ortega, Helena; Perella, Chiara; Poddubnyy, Denis; Pournara, Effie; Zielińska, Agnieszka; Baranauskaite, Asta; Sadhu, Sanchayita; Schulz, Barbara; Rissler, Michael Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P261 Early and accurate diagnosis of patients with axial spondyloarthritis using machine learning: a predictive analysis from electronic health records in the United Kingdom. (23rd April 2022) Authors: Sengupta, Raj; Narasimham, Shruti; Mato, Borja S; Meglic, Matic; Perella, Chiara; Pamies, Paula; Emery, Paul Journal: Rheumatology Issue: Volume 61(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial. (October 2021) Authors: Poddubnyy, Denis; Pournara, Effie; Zielińska, Agnieszka; Baranauskaite, Asta; Jiménez, Alejandro Muñoz; Sadhu, Sanchayita; Schulz, Barbara; Rissler, Michael; Perella, Chiara; Marzo-Ortega, Helena Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis. (1st September 2022) Authors: Reich, Kristian; Baraliakos, Xenophon; Coates, Laura C.; Elewski, Boni; Bao, Weibin; Kasparek, Torben; Gaillez, Corine; Pournara, Effie; Aassi, Maher; Perella, Chiara; Gottlieb, Alice B. Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis. (7th June 2022) Authors: Reich, Kristian; Baraliakos, Xenophon; Coates, Laura C.; Elewski, Boni; Bao, Weibin; Kasparek, Torben; Gaillez, Corine; Pournara, Effie; Aassi, Maher; Perella, Chiara; Gottlieb, Alice B. Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial. Issue 5 (17th December 2020) Authors: Baraliakos, Xenofon; Gossec, Laure; Pournara, Effie; Jeka, Slawomir; Mera-Varela, Antonio; D'Angelo, Salvatore; Schulz, Barbara; Rissler, Michael; Nagar, Kriti; Perella, Chiara; Coates, Laura C Journal: Annals of the rheumatic diseases Issue: Volume 80:Issue 5(2021) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗